Equity Overview
Price & Market Data
Price: $3.15
Daily Change: +$0.0046 / 0.15%
Range: $3.10 - $3.23
Market Cap: $6,886,960
Volume: 8,545
Performance Metrics
1 Week: 0.16%
1 Month: -24.59%
3 Months: -27.32%
6 Months: -72.42%
1 Year: -90.80%
YTD: -25.81%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country: Germany
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development of colorectal cancer screening product. The company was founded in 2008 and is based in Mainz, Germany.